This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA640005; GEO: GSE152668 |
| Type | Umbrella project |
| Publications | Veazey KJ et al., "CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.", Leukemia, 2020 Dec;34(12):3269-3285 |
| Submission | Registration date: 17-Jun-2020
Santos Lab, Epigenetics and Molecular Carcinogenesis, UT MD Anderson Cancer Center |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 31 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 31 |
| GEO DataSets | 4 |
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA640008 | Homo sapiens | CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas [ChIP-seq] (Santos Lab, Epigenetics and...) |
|
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA640010 | Homo sapiens | CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas [RNA-seq_Toledo] (Santos Lab, Epigenetics and...) | | PRJNA640009 | Mus musculus | CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas [RNA-seq_MEF] (Santos Lab, Epigenetics and...) |
|